Bio-Rad Laboratories Inc logo

Bio-Rad Laboratories Inc - Class A

5
1
NYSE:BIO (USA)   Class A
$ 330.53 +2.17 (+0.66%) 01:00 PM EST
At Loss
P/B:
1.23
Volume:
40.54K
Avg Vol (2M):
208.05K
Trade In:
Volume:
40.54K
At Loss
Avg Vol (2M):
208.05K

Business Description

Bio-Rad Laboratories Inc logo
Bio-Rad Laboratories Inc
NAICS : 334516 SIC : 3826
ISIN : US0905722072

Share Class Description:

BIO: Class A
Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Name Current Vs Industry Vs History
Cash-To-Debt 1.17
Equity-to-Asset 0.71
Debt-to-Equity 0.19
Debt-to-EBITDA -1.72
Interest Coverage 6.23
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.08
Distress
Grey
Safe
Beneish M-Score -2.45
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 40.86
9-Day RSI 43.27
14-Day RSI 44.82
6-1 Month Momentum % 15.6
12-1 Month Momentum % 3.79

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.14
Quick Ratio 4.52
Cash Ratio 3.26
Days Inventory 244.87
Days Sales Outstanding 65.03
Days Payable 37.72

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 1.5
Shareholder Yield % 4.31

Financials (Next Earnings Date:2025-02-14 Est.)

BIO's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:BIO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Bio-Rad Laboratories Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2,580.209
EPS (TTM) ($) -27.33
Beta 1.1
Volatility % 36.83
14-Day RSI 44.82
14-Day ATR ($) 10.708563
20-Day SMA ($) 335.1175
12-1 Month Momentum % 3.79
52-Week Range ($) 262.12 - 387.99
Shares Outstanding (Mil) 28

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bio-Rad Laboratories Inc Filings

Filing Date Document Date Form
No Filing Data

Bio-Rad Laboratories Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Bio-Rad Laboratories Inc Frequently Asked Questions

What is Bio-Rad Laboratories Inc(BIO)'s stock price today?
The current price of BIO is $330.53. The 52 week high of BIO is $387.99 and 52 week low is $262.12.
When is next earnings date of Bio-Rad Laboratories Inc(BIO)?
The next earnings date of Bio-Rad Laboratories Inc(BIO) is 2025-02-14 Est..
Does Bio-Rad Laboratories Inc(BIO) pay dividends? If so, how much?
Bio-Rad Laboratories Inc(BIO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1